Utility of FDG-PET scanning in lymphoma by WHO classification. - Wikidata - awgldk - TriplyDB

Utility of FDG-PET scanning in lymphoma by WHO classification.

Utility of FDG-PET scanning in lymphoma by WHO classification.

http://www.wikidata.org/entity/Q44280933

about

Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.FDG-PET/CT in lymphoma.Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification 18F-FDG PET/CT imaging in oncology FDG PET-CT in follicular lymphoma: a case-based evidence review.Primary parotid gland lymphoma: a case report.Revisiting the Marrow Metabolic Changes after Chemotherapy in Lymphoma: A Step towards Personalized Care.IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.The role of PET imaging in lymphoma.18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by (18)F-FDG PET/CT.Promise and pitfalls of quantitative imaging in oncology clinical trials.Positron emission tomographic scans in lymphoma: convention and controversy.The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Diagnosis of the jejunoileal lymphoma by double-balloon endoscopy.Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma.FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.PET/CT in the management of haematological malignancies.Predictive and prognostic value of FDG-PET.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?FDG-PET imaging in hematological malignancies Lymphoma of the breast in a male patient.PET imaging in lymphoma.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Magnetic resonance imaging of malignant lymphoma.Impact of FDG-PET/CT in the management of lymphoma.Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience.Advances in oncologic imaging: update on 5 common cancers.FDG PET/CT in children and adolescents with lymphoma.

P2860

Q26851987-6FFD7634-7712-4A8B-B06E-F2CDB0656BFE Q26863624-9176B754-A673-4C7A-BEB0-2E8929DBEF0F Q30491972-899E9569-4DC0-40FF-AD46-F41114982930 Q33642244-8E5656C9-5583-4789-9F3A-2DFE02F869D2 Q33829759-4CCB7E56-1898-4EAB-B49C-8399D9816B5E Q34408847-7C549F39-14CA-4BD5-A699-01EE1C4653A7 Q34663865-B7A3D823-C77B-4292-AF09-2B625221D9B0 Q35006097-1EC2DE36-84E5-437E-A1DF-6C347AB14F0A Q35080079-06DEF7E1-089F-4701-B550-546213073FA3 Q35206486-3DB914E4-67D2-48E5-8BB8-68A82A922CD6 Q35238224-029F1D9B-815C-4EB6-9EBC-01E2CC875BFA Q35587163-CAF61E7A-B0F9-4EF5-9024-E5A6AD3659FE Q35880451-E6997003-944C-4CEF-AC4D-E650FCDC37FD Q36078761-459AE970-43F7-4933-B28C-467EF6C9339F Q36230884-21F5BE68-DC8D-4A3E-8314-0542B5F7D191 Q36303765-2FAA78F4-3A31-404B-B3B2-BB9DC935136B Q36399538-E34C5641-F469-4BF6-9D65-448A325D3566 Q36663969-6EC9F8C5-439C-4CCA-896A-5C4303E539AC Q36677699-CF9E0261-AC5C-4A54-BD91-16F7158E442B Q36693166-D5204E20-E58B-4234-B5D0-CC3AF1DC2B4E Q36694607-DD2CD208-37F1-4CC6-AA07-C0D9BFBFAD7E Q36838768-06E9F185-5A63-4AB1-A05D-44A25A102919 Q36911500-C43C6CBD-6AA9-42A0-B65A-41FB6A67FD7A Q36985532-AC04C2D1-CAA9-4829-B344-CB89020D870D Q37088536-D4B92F1D-80D5-4868-8DAC-2EAC96DB9F0C Q37129057-CB8DBEDA-C48F-4E6B-8187-E22FE3E799CA Q37144956-E58AAD6F-1D69-4B89-B4BD-4BC0037860DA Q37224102-3DC53A64-1DBB-4B40-8F19-73DC757033C4 Q37240835-EE817BFF-D8F7-422F-BE39-BEB288E7FBD2 Q37242788-F3988C21-88C9-446E-B27D-99DDD1F100C0 Q37271814-2AD0524A-690B-4CF6-9D01-FCDA356E903A Q37632114-CB8111E3-E10F-4F34-B846-6A53BE9EBE48 Q37787095-DDAFC5CB-259A-4B64-A05F-2E166D446798 Q37810092-AAF9FA2E-DF09-40B3-86AF-5C225D7C218B Q37863688-BD715F3E-3F97-48A1-AFD8-FCC7AA76FC07 Q37865544-9640D23A-0675-4E2B-9EBC-68F51AF90CAB Q37950857-FE6867B9-609E-4742-B7AA-B41A84B470A7 Q38015946-10929F50-C07E-41BF-99F0-44D170932E15 Q38052458-5486E7F5-33FB-412D-A51C-BA383EBD25BB Q38092706-5F74FEF8-5D26-4BB6-9FE7-2D8F7C4BA160

P2860

Utility of FDG-PET scanning in lymphoma by WHO classification.

http://www.wikidata.org/entity/Q44280933

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Utility of FDG-PET scanning in lymphoma by WHO classification.

@en

Utility of FDG-PET scanning in lymphoma by WHO classification.

@nl

type

label

Utility of FDG-PET scanning in lymphoma by WHO classification.

@en

Utility of FDG-PET scanning in lymphoma by WHO classification.

@nl

prefLabel

Utility of FDG-PET scanning in lymphoma by WHO classification.

@en

Utility of FDG-PET scanning in lymphoma by WHO classification.

@nl

P1433

Q44280933-81F3CA1E-F18B-497C-95D4-223106FCE934

P1476

Q44280933-B8FDA30E-1889-459B-B41D-F7395C7701B7

P2093

Q44280933-08442D9E-486B-4610-84E8-988D0C236BFA

Q44280933-0D234992-4C93-448F-A570-BD0D8D0C926D

Q44280933-13E96248-11E9-4C36-8678-8DCAD2F4EE5C

Q44280933-2F8FE958-456A-422A-802B-FA0A37408581

Q44280933-5B3DECAD-25BE-4AB7-BEDA-6C3319F9B16E

Q44280933-5C4EA899-0C87-42F7-A36D-8CC5D04DB646

Q44280933-613DB3EB-0228-4E89-AF84-E6B4E77A5E18

Q44280933-63C5574E-0E8C-468F-A5BD-E1529FDA77B0

Q44280933-80256B39-190B-4DA3-ACAA-1AFB40FB5E38

Q44280933-82F569AD-7FF3-43CD-9432-EE0D67E5D601

P304

Q44280933-4C916859-AD0A-4556-B82F-7BC795EA4CC1

P31

Q44280933-D4047244-49A9-4943-BAFB-46B996E6AB85

P356

Q44280933-A690AE4F-1687-4B33-94CD-83D0E78C1B66

P407

Q44280933-F212015B-4D20-4B86-9F46-2CE3A8696289

P433

Q44280933-B19D0157-E4DF-4411-A059-6EBD9ED6D54F

P478

Q44280933-FCF2DA99-0A0C-4DC0-8FE0-85D51A851D3A

P577

Q44280933-BA8B9F10-1757-44A4-929C-863F6B359A9A

P5875

Q44280933-8429EB2C-3DA9-4E10-B175-512433FCBCDA

P698

Q44280933-8CD2D736-3416-4584-81FE-419E28539949

P921

Q44280933-6DED35BE-73D7-4B56-9B06-54ECEF80537A

P356

BLOOD-2002-09-2778

P1433

P1476

Utility of FDG-PET scanning in lymphoma by WHO classification.

@en

P2093

Abass Alavi

http://www.w3.org/2001/XMLSchema#string

Adam Bagg

http://www.w3.org/2001/XMLSchema#string

Amit Mehrotra

http://www.w3.org/2001/XMLSchema#string

Gary Baker

http://www.w3.org/2001/XMLSchema#string

Hongming Zhuang

http://www.w3.org/2001/XMLSchema#string

Jo-Anne Vergilio

http://www.w3.org/2001/XMLSchema#string

Khozaim Nakhoda

http://www.w3.org/2001/XMLSchema#string

Liang Guan

http://www.w3.org/2001/XMLSchema#string

Lisa Downs

http://www.w3.org/2001/XMLSchema#string

Rebecca Elstrom

http://www.w3.org/2001/XMLSchema#string

P304

3875-3876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-09-2778

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10946874

http://www.w3.org/2001/XMLSchema#string

P698

12531812

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin